Considering that inhibitors of the renin–angiotensin–aldosterone system, particularly angiotensin-converting enzyme inhibitors, are commonly used in the treatment of hypertension in the general population but not during pregnancy, treatment strategies related to this system are not included in this study [72]. The gene discussed is REN; the disease is hypertensive disorder.